Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Alinwell Tirzepatide Review: $299/Month After the Intake, Not $199 (2026)

Alinwell charges $299 a month for compounded tirzepatide, billed every 30 days. The $199 on every marketing surface covers the first month only.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$130/mo below the $279 median
Market
$109–$429/mo across 388 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Care Bare Rx

LegitScript-certified, with oral as well as injectable tirzepatide and a real brand Ozempic pathway — but per-dose pricing is quiz-gated.

From $199/mo*

Check Care Bare Rx availability

Alinwell charges $299 a month for compounded tirzepatide, billed every 30 days until you cancel, and that number only surfaces once the intake is finished. The "FROM $199/MO" on the homepage and the plan screen is a first-month price rather than a rate; the checkout strikes $299 beside it and labels the gap "$100 off first month." Prepay moves the figure to $269 a month on three months and $239 on six. Everything below was read on 1 September 2026, most of it only after a 31-screen walk of Alinwell's own funnel.1

What the funnel shows, and when it shows it

Nothing carries a price through the first thirty screens. The treatment pages say only "AVAILABLE BY CONSULTATION," and the estimator promises plans "from $149/mo, confirmed after provider review." The ladder then arrives all at once, and to Alinwell's credit it arrives labeled, with the intro discount, the standing rate and both prepay rungs on a single screen. What that candor exposes is awkward, because the three-month plan badged MOST POPULAR costs $269 a month, which is $70 more per month than the figure the site advertises everywhere.

§ Alinwell — the tirzepatide ladder, read at checkout 1 September 2026

How you buyWhat you hand overWhat the site advertises
First month only$199 once"FROM $199/MO" — an intro price
Month to month$299 every 30 daysthe standing rate, shown only at checkout
3 months up front$269 a monthbadged MOST POPULAR
6 months up front$239 a monthstruck against the 3-month rate
The advertised figure is the top row and nothing else. The MOST POPULAR rung costs $70 a month more than the price the site puts on its homepage.

The pharmacies on the certificates of analysis

Each treatment page carries a VIEW CERTIFICATE control, and the documents behind it name two compounders with street addresses: Emerald Compounding Pharmacy of Tampa, Florida, and Boudreaux's New Drug Store of Lake Charles, Louisiana. That is more disclosure than most providers we review publish. What it leaves open deserves saying just as plainly: the site never states which of the two fills a given order, and "503A" and "503B" appear zero times across every page and payload read. No clinician, medical group or NPI is named either.

A placeholder address, and three cancellation rules

The Terms and the Privacy Policy both give the company's mailing address as "123 Example Street, Suite 100, Your City, WI, 92308," unedited template boilerplate left live on both legal pages. The contact page publishes a real clinic address in Southlake, Texas. Cancellation is in a similar condition, with the Terms asking for 48 hours' notice, the treatment-page FAQ asking for 30 days, and the checkout and homepage marquee both promising "cancel anytime." Only one of the three can govern the charge that matters.

The brand-vs-compounded question

This is compounded tirzepatide, made to order with glycine, and it is not Zepbound or any other FDA-approved finished product. Our guide to whether compounded tirzepatide is still legal in 2026 sets out where that now stands.

How the care model holds up

The consultation, the dose changes and expedited shipping all sit inside the figure, and nothing already dispensed can be refunded. The plan screen announces "You're Approved" before a clinician has opened the file, which the very next screen quietly concedes.

Does the drug work? (Separate from the provider)

Judge the seller on price, disclosure and paperwork; judge the molecule on its trials, which are strong. Tirzepatide took roughly 15% to 21% of body weight over 72 weeks in SURMOUNT-12, and beat semaglutide head to head in SURMOUNT-53. Both were run on the brand product at approved doses, a distinction our tirzepatide evidence guide works through.

The honest verdict

Alinwell publishes what many sellers hide and hides what most of them publish. The pharmacies are named on documents anyone can open, while the price you will actually pay sits behind thirty questions. Set against Andrew Meds, which prints the same $299 on an open product page but whose own funnels did not offer tirzepatide when they were walked, Alinwell at least sells the drug it advertises. Clume Health is the cleaner comparison on disclosure, showing a $259 month-to-month rate beside its commitment rate before any intake, which leaves Alinwell's ladder both dearer and later. Our ranked best tirzepatide providers list has the rest of the field.

Frequently asked questions

How much does tirzepatide cost at Alinwell?

$299 a month, charged every 30 days; the advertised $199 covers the first month only.

Does Alinwell name its pharmacy?

Only on its certificates of analysis, which name two compounders. No 503A or 503B designation appears anywhere on the site.

Can you cancel at any time?

Three incompatible rules are live at once: 48 hours' notice in the Terms, 30 days in the FAQ, and "cancel anytime" at checkout.

References(3)

  1. Alinwell LLC (2026). Compounded tirzepatide plan pricing at checkout, published certificates of analysis, Terms of Use, Privacy Policy and contact page. alinwell.com. https://alinwell.com/
  2. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  3. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated September 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.